Basic info
Industry
biotechnology research
Sectors
Biotechnology
biotechnology
Antibiotic resistant infectious disease
rare disease
Pediatric Crohn’s disease
bioterrorism
Acute radiation syndrome
oncology
Infectious disease
Cutaneous T-Cell Lymphoma
Acute radiation enteritis
rare cancers
ricin toxin vaccine
oral mucositis
Photodynamic therapy
Innate defense regulator
Ricin exposure
Melioidosis
Health Care
Hypericin
heat stable vaccines
Orphan diseases
Head and neck cancer
Medical
Biopharma
Ebola
Date founded
1987
Funding rounds raised
Total raised
$1.5M
from 7 investors over 7 rounds
S
Soligenix, Inc. raised $1.2M on November 15, 2022
Investors: New Jersey Economic Development Authority (NJEDA)
S
Soligenix, Inc. raised $1.4M on April 19, 2022
Investors: New Jersey Economic Development Authority (NJEDA)
S
Soligenix, Inc. raised $865K on June 9, 2021
Investors: New Jersey Economic Development Authority (NJEDA)
S
Soligenix, Inc. raised $1.5M on December 28, 2020
Investors: National Institutes of Health
S
Soligenix, Inc. raised $840K on May 7, 2020
Investors: New Jersey Economic Development Authority (NJEDA)
S
Soligenix, Inc. raised $634K on July 25, 2016
Investors: National Institute of Allergy and Infectious Diseases (NIAID) and Biomedical Advanced Research and Development Authority (BARDA)